ID CNGB1_HUMAN Reviewed; 1251 AA. AC Q14028; H3BN09; O43636; Q13059; Q14029; Q9UMG2; DT 01-NOV-1997, integrated into UniProtKB/Swiss-Prot. DT 01-SEP-2009, sequence version 2. DT 24-JAN-2024, entry version 193. DE RecName: Full=Cyclic nucleotide-gated cation channel beta-1; DE AltName: Full=Cyclic nucleotide-gated cation channel 4; DE Short=CNG channel 4; DE Short=CNG-4; DE Short=CNG4; DE AltName: Full=Cyclic nucleotide-gated cation channel gamma; DE AltName: Full=Cyclic nucleotide-gated cation channel modulatory subunit; DE AltName: Full=Cyclic nucleotide-gated channel beta-1; DE Short=CNG channel beta-1; DE AltName: Full=Glutamic acid-rich protein; DE Short=GARP; GN Name=CNGB1; Synonyms=CNCG2, CNCG3L, CNCG4, RCNC2; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS RCNC2A AND RCNC2B). RC TISSUE=Retina; RX PubMed=7682292; DOI=10.1038/362764a0; RA Chen T.-Y., Peng Y.-W., Dhallan R.S., Ahamed B., Reed R.R., Yau K.-W.; RT "A new subunit of the cyclic nucleotide-gated cation channel in retinal RT rods."; RL Nature 362:764-767(1993). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM GARP2), AND VARIANT HIS-100. RC TISSUE=Retina; RX PubMed=7590744; DOI=10.1006/geno.1995.1102; RA Ardell M.D., Makhija A.K., Oliveira L., Miniou P., Viegas-Pequignot E., RA Pittler S.J.; RT "cDNA, gene structure, and chromosomal localization of human GAR1 (CNCG3L), RT a homolog of the third subunit of bovine photoreceptor cGMP-gated RT channel."; RL Genomics 28:32-38(1995). RN [3] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM RCNC2B), AND VARIANT HIS-100. RC TISSUE=Retina; RX PubMed=8766832; DOI=10.1016/0014-5793(96)00588-1; RA Ardell M.D., Aragon I., Oliveira L., Porche G.E., Burke E., Pittler S.J.; RT "The beta subunit of human rod photoreceptor cGMP-gated cation channel is RT generated from a complex transcription unit."; RL FEBS Lett. 389:213-218(1996). RN [4] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM RCNC2B), FUNCTION, AND VARIANT HIS-100. RC TISSUE=Retina; RX PubMed=9535905; DOI=10.1074/jbc.273.15.9148; RA Grunwald M.E., Yu W.P., Yu H.H., Yau K.W.; RT "Identification of a domain on the beta-subunit of the rod cGMP-gated RT cation channel that mediates inhibition by calcium-calmodulin."; RL J. Biol. Chem. 273:9148-9157(1998). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15616553; DOI=10.1038/nature03187; RA Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X., Xie G., RA Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A., Bajorek E., RA Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J., Buckingham J.M., RA Callen D.F., Campbell C.S., Campbell M.L., Campbell E.W., Caoile C., RA Challacombe J.F., Chasteen L.A., Chertkov O., Chi H.C., Christensen M., RA Clark L.M., Cohn J.D., Denys M., Detter J.C., Dickson M., RA Dimitrijevic-Bussod M., Escobar J., Fawcett J.J., Flowers D., Fotopulos D., RA Glavina T., Gomez M., Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., RA Grigoriev I., Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., RA Huang W., Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., RA Kobayashi A., Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., RA Lowry S., Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J., RA Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D., RA Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L., Rash S., RA Retterer J., Ricke D.O., Robinson D.L., Rodriguez A., Salamov A., RA Saunders E.H., Scott D., Shough T., Stallings R.L., Stalvey M., RA Sutherland R.D., Tapia R., Tesmer J.G., Thayer N., Thompson L.S., Tice H., RA Torney D.C., Tran-Gyamfi M., Tsai M., Ulanovsky L.E., Ustaszewska A., RA Vo N., White P.S., Williams A.L., Wills P.L., Wu J.-R., Wu K., Yang J., RA DeJong P., Bruce D., Doggett N.A., Deaven L., Schmutz J., Grimwood J., RA Richardson P., Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., RA Myers R.M., Rubin E.M., Pennacchio L.A.; RT "The sequence and analysis of duplication-rich human chromosome 16."; RL Nature 432:988-994(2004). RN [6] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases. RN [7] RP ALTERNATIVE SPLICING. RX PubMed=10717482; DOI=10.1016/s0378-1119(00)00023-8; RA Ardell M.D., Bedsole D.L., Schoborg R.V., Pittler S.J.; RT "Genomic organization of the human rod photoreceptor cGMP-gated cation RT channel beta-subunit gene."; RL Gene 245:311-318(2000). RN [8] RP MUTAGENESIS OF LEU-568. RX PubMed=15195096; DOI=10.1038/nn1266; RA Bradley J., Boenigk W., Yau K.-W., Frings S.; RT "Calmodulin permanently associates with rat olfactory CNG channels under RT native conditions."; RL Nat. Neurosci. 7:705-710(2004). RN [9] RP ALTERNATIVE SPLICING (ISOFORM GARP2), AND FUNCTION. RX PubMed=16407240; DOI=10.1074/jbc.m507488200; RA Pentia D.C., Hosier S., Cote R.H.; RT "The glutamic acid-rich protein-2 (GARP2) is a high affinity rod RT photoreceptor phosphodiesterase (PDE6)-binding protein that modulates its RT catalytic properties."; RL J. Biol. Chem. 281:5500-5505(2006). RN [10] RP CHARACTERIZATION OF THE GARPS PROTEINS. RX PubMed=16280326; DOI=10.1074/jbc.m505012200; RA Batra-Safferling R., Abarca-Heidemann K., Korschen H.G., Tziatzios C., RA Stoldt M., Budyak I., Willbold D., Schwalbe H., Klein-Seetharaman J., RA Kaupp U.B.; RT "Glutamic acid-rich proteins of rod photoreceptors are natively unfolded."; RL J. Biol. Chem. 281:1449-1460(2006). RN [11] RP ALTERNATIVE SPLICING (ISOFORM GARP2). RA Cote R.H.; RL Unpublished observations (MAY-2009). RN [12] RP VARIANT RP45 VAL-993. RX PubMed=11379879; DOI=10.1007/s004390100496; RA Bareil C., Hamel C.P., Delague V., Arnaud B., Demaille J., Claustres M.; RT "Segregation of a mutation in CNGB1 encoding the beta-subunit of the rod RT cGMP-gated channel in a family with autosomal recessive retinitis RT pigmentosa."; RL Hum. Genet. 108:328-334(2001). CC -!- FUNCTION: Subunit of cyclic nucleotide-gated (CNG) channels, CC nonselective cation channels, which play important roles in both visual CC and olfactory signal transduction. When associated with CNGA1, it is CC involved in the regulation of ion flow into the rod photoreceptor outer CC segment (ROS), in response to light-induced alteration of the levels of CC intracellular cGMP. CC -!- FUNCTION: Isoform GARP2 is a high affinity rod photoreceptor CC phosphodiesterase (PDE6)-binding protein that modulates its catalytic CC properties: it is a regulator of spontaneous activation of rod PDE6, CC thereby serving to lower rod photoreceptor 'dark noise' and allowing CC these sensory cells to operate at the single photon detection limit. CC -!- SUBUNIT: Tetramer formed of three CNGA1 and one CNGB1 modulatory CC subunits. {ECO:0000250}. CC -!- INTERACTION: CC Q14028; Q5ICW4: GRB14; Xeno; NbExp=2; IntAct=EBI-7959609, EBI-7639273; CC -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=4; CC Comment=There is no evidence for an ortholog to bovine GARP1 in the CC human genome.; CC Name=RCNC2B; CC IsoId=Q14028-1; Sequence=Displayed; CC Name=RCNC2A; CC IsoId=Q14028-2; Sequence=VSP_001110; CC Name=GARP2; Synonyms=GARP; CC IsoId=Q14028-3; Sequence=VSP_037921, VSP_037922; CC Name=4; CC IsoId=Q14028-4; Sequence=VSP_053421; CC -!- DISEASE: Retinitis pigmentosa 45 (RP45) [MIM:613767]: A retinal CC dystrophy belonging to the group of pigmentary retinopathies. Retinitis CC pigmentosa is characterized by retinal pigment deposits visible on CC fundus examination and primary loss of rod photoreceptor cells followed CC by secondary loss of cone photoreceptors. Patients typically have night CC vision blindness and loss of midperipheral visual field. As their CC condition progresses, they lose their far peripheral visual field and CC eventually central vision as well. {ECO:0000269|PubMed:11379879}. CC Note=The disease is caused by variants affecting the gene represented CC in this entry. CC -!- MISCELLANEOUS: [Isoform GARP2]: In the rod cells, the CNGB1 locus CC encodes the cyclic nucleotide-gated cation channel beta-1 subunit and CC several glutamic-acid-rich proteins (GARPs). {ECO:0000305}. CC -!- SIMILARITY: Belongs to the cyclic nucleotide-gated cation channel CC (TC 1.A.1.5) family. CNGB1 subfamily. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; L15296; AAA65620.1; -; Genomic_DNA. DR EMBL; L15297; AAA65619.1; -; Genomic_DNA. DR EMBL; U18945; AAA91633.1; -; mRNA. DR EMBL; U58837; AAB63387.1; -; mRNA. DR EMBL; AF042498; AAC04830.1; -; mRNA. DR EMBL; AC010543; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH471092; EAW82957.1; -; Genomic_DNA. DR CCDS; CCDS42169.1; -. [Q14028-1] DR CCDS; CCDS45495.1; -. [Q14028-3] DR CCDS; CCDS67042.1; -. [Q14028-4] DR PIR; A57652; A57652. DR PIR; S32538; S32538. DR PIR; S69275; S69275. DR RefSeq; NP_001129111.1; NM_001135639.1. [Q14028-3] DR RefSeq; NP_001273059.1; NM_001286130.1. [Q14028-4] DR RefSeq; NP_001288.3; NM_001297.4. [Q14028-1] DR PDB; 7RH9; EM; 2.61 A; B=454-1251. DR PDB; 7RHG; EM; 2.88 A; B=454-1251. DR PDB; 7RHH; EM; 3.31 A; B=454-1251. DR PDB; 7RHI; EM; 3.31 A; B=454-1251. DR PDB; 7RHJ; EM; 2.88 A; B=454-1251. DR PDB; 7RHK; EM; 3.27 A; B=454-1251. DR PDB; 7RHL; EM; 3.03 A; B=454-1251. DR PDB; 8DGH; NMR; -; B=1128-1139. DR PDB; 8DGK; NMR; -; B=565-576. DR PDBsum; 7RH9; -. DR PDBsum; 7RHG; -. DR PDBsum; 7RHH; -. DR PDBsum; 7RHI; -. DR PDBsum; 7RHJ; -. DR PDBsum; 7RHK; -. DR PDBsum; 7RHL; -. DR PDBsum; 8DGH; -. DR PDBsum; 8DGK; -. DR AlphaFoldDB; Q14028; -. DR EMDB; EMD-24458; -. DR EMDB; EMD-24460; -. DR EMDB; EMD-24461; -. DR EMDB; EMD-24462; -. DR EMDB; EMD-24463; -. DR EMDB; EMD-24464; -. DR EMDB; EMD-24465; -. DR SMR; Q14028; -. DR BioGRID; 107658; 5. DR IntAct; Q14028; 2. DR MINT; Q14028; -. DR STRING; 9606.ENSP00000251102; -. DR TCDB; 1.A.1.5.3; the voltage-gated ion channel (vic) superfamily. DR GlyGen; Q14028; 1 site, 1 O-linked glycan (1 site). DR iPTMnet; Q14028; -. DR PhosphoSitePlus; Q14028; -. DR BioMuta; CNGB1; -. DR DMDM; 257051004; -. DR EPD; Q14028; -. DR MassIVE; Q14028; -. DR PaxDb; 9606-ENSP00000251102; -. DR PeptideAtlas; Q14028; -. DR ProteomicsDB; 41062; -. DR ProteomicsDB; 59797; -. [Q14028-1] DR ProteomicsDB; 59798; -. [Q14028-2] DR ProteomicsDB; 59799; -. [Q14028-3] DR Antibodypedia; 48567; 143 antibodies from 21 providers. DR DNASU; 1258; -. DR Ensembl; ENST00000251102.13; ENSP00000251102.8; ENSG00000070729.14. [Q14028-1] DR Ensembl; ENST00000311183.8; ENSP00000311670.4; ENSG00000070729.14. [Q14028-3] DR Ensembl; ENST00000564448.5; ENSP00000454633.1; ENSG00000070729.14. [Q14028-4] DR GeneID; 1258; -. DR KEGG; hsa:1258; -. DR MANE-Select; ENST00000251102.13; ENSP00000251102.8; NM_001297.5; NP_001288.3. DR UCSC; uc002emt.3; human. [Q14028-1] DR AGR; HGNC:2151; -. DR CTD; 1258; -. DR DisGeNET; 1258; -. DR GeneCards; CNGB1; -. DR GeneReviews; CNGB1; -. DR HGNC; HGNC:2151; CNGB1. DR HPA; ENSG00000070729; Tissue enriched (retina). DR MalaCards; CNGB1; -. DR MIM; 600724; gene. DR MIM; 613767; phenotype. DR neXtProt; NX_Q14028; -. DR OpenTargets; ENSG00000070729; -. DR Orphanet; 791; Retinitis pigmentosa. DR PharmGKB; PA26662; -. DR VEuPathDB; HostDB:ENSG00000070729; -. DR eggNOG; KOG0499; Eukaryota. DR GeneTree; ENSGT00940000154824; -. DR HOGENOM; CLU_005746_11_0_1; -. DR InParanoid; Q14028; -. DR OMA; YWASAFE; -. DR OrthoDB; 74296at2759; -. DR PhylomeDB; Q14028; -. DR TreeFam; TF318250; -. DR PathwayCommons; Q14028; -. DR Reactome; R-HSA-2485179; Activation of the phototransduction cascade. DR Reactome; R-HSA-2514859; Inactivation, recovery and regulation of the phototransduction cascade. DR Reactome; R-HSA-381753; Olfactory Signaling Pathway. [Q14028-3] DR Reactome; R-HSA-5620916; VxPx cargo-targeting to cilium. DR SignaLink; Q14028; -. DR BioGRID-ORCS; 1258; 15 hits in 1142 CRISPR screens. DR ChiTaRS; CNGB1; human. DR GeneWiki; CNGB1; -. DR GenomeRNAi; 1258; -. DR Pharos; Q14028; Tbio. DR PRO; PR:Q14028; -. DR Proteomes; UP000005640; Chromosome 16. DR RNAct; Q14028; Protein. DR Bgee; ENSG00000070729; Expressed in buccal mucosa cell and 136 other cell types or tissues. DR ExpressionAtlas; Q14028; baseline and differential. DR GO; GO:0060170; C:ciliary membrane; TAS:Reactome. DR GO; GO:0030660; C:Golgi-associated vesicle membrane; TAS:Reactome. DR GO; GO:0017071; C:intracellular cyclic nucleotide activated cation channel complex; IBA:GO_Central. DR GO; GO:0001750; C:photoreceptor outer segment; IBA:GO_Central. DR GO; GO:0005886; C:plasma membrane; IBA:GO_Central. DR GO; GO:0043195; C:terminal bouton; IEA:Ensembl. DR GO; GO:1902495; C:transmembrane transporter complex; IDA:UniProtKB. DR GO; GO:0030552; F:cAMP binding; IEA:UniProtKB-KW. DR GO; GO:0030553; F:cGMP binding; IDA:UniProtKB. DR GO; GO:0005222; F:intracellular cAMP-activated cation channel activity; IBA:GO_Central. DR GO; GO:0005223; F:intracellular cGMP-activated cation channel activity; IDA:UniProtKB. DR GO; GO:0015276; F:ligand-gated monoatomic ion channel activity; TAS:ProtInc. DR GO; GO:0044877; F:protein-containing complex binding; IBA:GO_Central. DR GO; GO:0050911; P:detection of chemical stimulus involved in sensory perception of smell; ISS:ARUK-UCL. DR GO; GO:0050908; P:detection of light stimulus involved in visual perception; IMP:UniProtKB. DR GO; GO:0099105; P:ion channel modulating, G protein-coupled receptor signaling pathway; ISS:ARUK-UCL. DR GO; GO:0051899; P:membrane depolarization; ISS:ARUK-UCL. DR GO; GO:0098655; P:monoatomic cation transmembrane transport; IBA:GO_Central. DR GO; GO:0006812; P:monoatomic cation transport; IDA:UniProtKB. DR GO; GO:0021630; P:olfactory nerve maturation; ISS:ARUK-UCL. DR GO; GO:0045494; P:photoreceptor cell maintenance; IEA:Ensembl. DR GO; GO:0035845; P:photoreceptor cell outer segment organization; IEA:Ensembl. DR GO; GO:0007602; P:phototransduction; IEA:Ensembl. DR GO; GO:0010628; P:positive regulation of gene expression; IEA:Ensembl. DR GO; GO:0033365; P:protein localization to organelle; IEA:Ensembl. DR GO; GO:0051480; P:regulation of cytosolic calcium ion concentration; IEA:Ensembl. DR GO; GO:1990834; P:response to odorant; ISS:ARUK-UCL. DR GO; GO:0001895; P:retina homeostasis; IMP:UniProtKB. DR GO; GO:0007601; P:visual perception; TAS:ProtInc. DR CDD; cd00038; CAP_ED; 1. DR Gene3D; 1.10.287.70; -; 1. DR Gene3D; 1.10.287.630; Helix hairpin bin; 1. DR Gene3D; 2.60.120.10; Jelly Rolls; 1. DR InterPro; IPR018488; cNMP-bd_CS. DR InterPro; IPR000595; cNMP-bd_dom. DR InterPro; IPR018490; cNMP-bd_dom_sf. DR InterPro; IPR014710; RmlC-like_jellyroll. DR PANTHER; PTHR45638:SF16; CYCLIC NUCLEOTIDE-GATED CATION CHANNEL BETA-1; 1. DR PANTHER; PTHR45638; CYCLIC NUCLEOTIDE-GATED CATION CHANNEL SUBUNIT A; 1. DR Pfam; PF00027; cNMP_binding; 1. DR SMART; SM00100; cNMP; 1. DR SUPFAM; SSF51206; cAMP-binding domain-like; 1. DR SUPFAM; SSF81324; Voltage-gated potassium channels; 1. DR PROSITE; PS00888; CNMP_BINDING_1; 1. DR PROSITE; PS00889; CNMP_BINDING_2; 1. DR PROSITE; PS50042; CNMP_BINDING_3; 1. DR Genevisible; Q14028; HS. PE 1: Evidence at protein level; KW 3D-structure; Alternative splicing; cAMP; cAMP-binding; Disease variant; KW Ion channel; Ion transport; Ligand-gated ion channel; Membrane; KW Nucleotide-binding; Olfaction; Reference proteome; Retinitis pigmentosa; KW Sensory transduction; Transmembrane; Transmembrane helix; Transport; KW Vision. FT CHAIN 1..1251 FT /note="Cyclic nucleotide-gated cation channel beta-1" FT /id="PRO_0000219323" FT TOPO_DOM 343..656 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 657..675 FT /note="Helical; Name=H1" FT /evidence="ECO:0000255" FT TOPO_DOM 676..689 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 690..708 FT /note="Helical; Name=H2" FT /evidence="ECO:0000255" FT TOPO_DOM 709..733 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 734..753 FT /note="Helical; Name=H3" FT /evidence="ECO:0000255" FT TOPO_DOM 754..790 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 791..813 FT /note="Helical; Name=H4" FT /evidence="ECO:0000255" FT TOPO_DOM 814..857 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 858..877 FT /note="Helical; Name=H5" FT /evidence="ECO:0000255" FT TOPO_DOM 878..961 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 962..982 FT /note="Helical; Name=H6" FT /evidence="ECO:0000255" FT TOPO_DOM 983..1251 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT REGION 1..75 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 121..151 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 172..252 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 314..561 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 585..619 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 1151..1251 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOTIF 568..578 FT /note="IQ-like" FT COMPBIAS 26..52 FT /note="Acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 53..69 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 334..351 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 352..375 FT /note="Acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 383..404 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 405..422 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 437..451 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 512..527 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 585..602 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 1166..1180 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 1182..1204 FT /note="Pro residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT BINDING 970..1109 FT /ligand="3',5'-cyclic AMP" FT /ligand_id="ChEBI:CHEBI:58165" FT /evidence="ECO:0000250" FT BINDING 1030 FT /ligand="3',5'-cyclic AMP" FT /ligand_id="ChEBI:CHEBI:58165" FT /evidence="ECO:0000255" FT BINDING 1042 FT /ligand="3',5'-cyclic AMP" FT /ligand_id="ChEBI:CHEBI:58165" FT /evidence="ECO:0000255" FT VAR_SEQ 1..628 FT /note="Missing (in isoform RCNC2A)" FT /evidence="ECO:0000305" FT /id="VSP_001110" FT VAR_SEQ 189..194 FT /note="Missing (in isoform 4)" FT /evidence="ECO:0000305" FT /id="VSP_053421" FT VAR_SEQ 292..299 FT /note="ISILPGGQ -> RVMGAGGL (in isoform GARP2)" FT /evidence="ECO:0000303|PubMed:7590744" FT /id="VSP_037921" FT VAR_SEQ 300..1251 FT /note="Missing (in isoform GARP2)" FT /evidence="ECO:0000303|PubMed:7590744" FT /id="VSP_037922" FT VARIANT 100 FT /note="R -> H (in dbSNP:rs13336595)" FT /evidence="ECO:0000269|PubMed:7590744, FT ECO:0000269|PubMed:8766832, ECO:0000269|PubMed:9535905" FT /id="VAR_058691" FT VARIANT 479 FT /note="L -> I (in dbSNP:rs2303783)" FT /id="VAR_059225" FT VARIANT 535 FT /note="V -> A (in dbSNP:rs12927214)" FT /id="VAR_059226" FT VARIANT 731 FT /note="N -> K (in dbSNP:rs376270)" FT /id="VAR_059227" FT VARIANT 745 FT /note="L -> I (in dbSNP:rs10459809)" FT /id="VAR_059228" FT VARIANT 911 FT /note="K -> R (in dbSNP:rs2303785)" FT /id="VAR_059229" FT VARIANT 961 FT /note="A -> S (in dbSNP:rs16942445)" FT /id="VAR_059230" FT VARIANT 993 FT /note="G -> V (in RP45; dbSNP:rs121918532)" FT /evidence="ECO:0000269|PubMed:11379879" FT /id="VAR_060491" FT MUTAGEN 568 FT /note="L->E: Loss of calcium/calmodulin modulation." FT /evidence="ECO:0000269|PubMed:15195096" FT CONFLICT 128 FT /note="I -> V (in Ref. 5; AC010543)" FT /evidence="ECO:0000305" FT CONFLICT 1148..1149 FT /note="QQ -> HE (in Ref. 2; AAB63387 and 1; FT AAA65619/AAA65620)" FT /evidence="ECO:0000305" FT CONFLICT 1207..1208 FT /note="RP -> SC (in Ref. 2; AAB63387 and 1; FT AAA65619/AAA65620)" FT /evidence="ECO:0000305" FT TURN 650..652 FT /evidence="ECO:0007829|PDB:7RH9" FT HELIX 654..679 FT /evidence="ECO:0007829|PDB:7RH9" FT STRAND 685..687 FT /evidence="ECO:0007829|PDB:7RH9" FT HELIX 688..707 FT /evidence="ECO:0007829|PDB:7RH9" FT HELIX 710..712 FT /evidence="ECO:0007829|PDB:7RH9" FT STRAND 715..717 FT /evidence="ECO:0007829|PDB:7RH9" FT STRAND 720..722 FT /evidence="ECO:0007829|PDB:7RH9" FT HELIX 725..734 FT /evidence="ECO:0007829|PDB:7RH9" FT HELIX 736..745 FT /evidence="ECO:0007829|PDB:7RH9" FT HELIX 759..767 FT /evidence="ECO:0007829|PDB:7RH9" FT HELIX 770..782 FT /evidence="ECO:0007829|PDB:7RH9" FT STRAND 783..785 FT /evidence="ECO:0007829|PDB:7RH9" FT HELIX 787..816 FT /evidence="ECO:0007829|PDB:7RH9" FT STRAND 820..824 FT /evidence="ECO:0007829|PDB:7RH9" FT STRAND 829..832 FT /evidence="ECO:0007829|PDB:7RHL" FT HELIX 833..843 FT /evidence="ECO:0007829|PDB:7RH9" FT HELIX 855..886 FT /evidence="ECO:0007829|PDB:7RH9" FT HELIX 888..906 FT /evidence="ECO:0007829|PDB:7RH9" FT HELIX 911..928 FT /evidence="ECO:0007829|PDB:7RH9" FT STRAND 929..931 FT /evidence="ECO:0007829|PDB:7RH9" FT HELIX 933..939 FT /evidence="ECO:0007829|PDB:7RH9" FT HELIX 942..959 FT /evidence="ECO:0007829|PDB:7RH9" FT HELIX 961..963 FT /evidence="ECO:0007829|PDB:7RH9" FT HELIX 968..977 FT /evidence="ECO:0007829|PDB:7RH9" FT STRAND 979..983 FT /evidence="ECO:0007829|PDB:7RH9" FT STRAND 988..990 FT /evidence="ECO:0007829|PDB:7RH9" FT STRAND 992..995 FT /evidence="ECO:0007829|PDB:7RHJ" FT STRAND 998..1005 FT /evidence="ECO:0007829|PDB:7RH9" FT STRAND 1007..1012 FT /evidence="ECO:0007829|PDB:7RH9" FT STRAND 1017..1022 FT /evidence="ECO:0007829|PDB:7RH9" FT STRAND 1027..1029 FT /evidence="ECO:0007829|PDB:7RHI" FT HELIX 1030..1033 FT /evidence="ECO:0007829|PDB:7RH9" FT STRAND 1036..1038 FT /evidence="ECO:0007829|PDB:7RH9" FT STRAND 1046..1058 FT /evidence="ECO:0007829|PDB:7RH9" FT HELIX 1059..1066 FT /evidence="ECO:0007829|PDB:7RH9" FT HELIX 1070..1083 FT /evidence="ECO:0007829|PDB:7RH9" FT HELIX 1107..1129 FT /evidence="ECO:0007829|PDB:7RHL" SQ SEQUENCE 1251 AA; 139678 MW; 7A45CB399EB2B20C CRC64; MLGWVQRVLP QPPGTPRKTK MQEEEEVEPE PEMEAEVEPE PNPEEAETES ESMPPEESFK EEEVAVADPS PQETKEAALT STISLRAQGA EISEMNSPSR RVLTWLMKGV EKVIPQPVHS ITEDPAQILG HGSTGDTGCT DEPNEALEAQ DTRPGLRLLL WLEQNLERVL PQPPKSSEVW RDEPAVATGA ASDPAPPGRP QEMGPKLQAR ETPSLPTPIP LQPKEEPKEA PAPEPQPGSQ AQTSSLPPTR DPARLVAWVL HRLEMALPQP VLHGKIGEQE PDSPGICDVQ TISILPGGQV EPDLVLEEVE PPWEDAHQDV STSPQGTEVV PAYEEENKAV EKMPRELSRI EEEKEDEEEE EEEEEEEEEE EVTEVLLDSC VVSQVGVGQS EEDGTRPQST SDQKLWEEVG EEAKKEAEEK AKEEAEEVAE EEAEKEPQDW AETKEEPEAE AEAASSGVPA TKQHPEVQVE DTDADSCPLM AEENPPSTVL PPPSPAKSDT LIVPSSASGT HRKKLPSEDD EAEELKALSP AESPVVAWSD PTTPKDTDGQ DRAASTASTN SAIINDRLQE LVKLFKERTE KVKEKLIDPD VTSDEESPKP SPAKKAPEPA PDTKPAEAEP VEEEHYCDML CCKFKHRPWK KYQFPQSIDP LTNLMYVLWL FFVVMAWNWN CWLIPVRWAF PYQTPDNIHH WLLMDYLCDL IYFLDITVFQ TRLQFVRGGD IITDKKDMRN NYLKSRRFKM DLLSLLPLDF LYLKVGVNPL LRLPRCLKYM AFFEFNSRLE SILSKAYVYR VIRTTAYLLY SLHLNSCLYY WASAYQGLGS THWVYDGVGN SYIRCYYFAV KTLITIGGLP DPKTLFEIVF QLLNYFTGVF AFSVMIGQMR DVVGAATAGQ TYYRSCMDST VKYMNFYKIP KSVQNRVKTW YEYTWHSQGM LDESELMVQL PDKMRLDLAI DVNYNIVSKV ALFQGCDRQM IFDMLKRLRS VVYLPNDYVC KKGEIGREMY IIQAGQVQVL GGPDGKSVLV TLKAGSVFGE ISLLAVGGGN RRTANVVAHG FTNLFILDKK DLNEILVHYP ESQKLLRKKA RRMLRSNNKP KEEKSVLILP PRAGTPKLFN AALAMTGKMG GKGAKGGKLA HLRARLKELA ALEAAAKQQE LVEQAKSSQD VKGEEGSAAP DQHTHPKEAA TDPPAPRTPP EPPGSPPSSP PPASLGRPEG EEEGPAEPEE HSVRICMSPG PEPGEQILSV KMPEEREEKA E //